Leadership

Although private equity investment provides a source of capital, some ASC leaders warn it could diminish physician control.

As private equity firms continue to enter the ASC market, some ASC leaders have found alternatives through affiliations with other practices. 

Jason Richardson is the CEO of Boulder, Colo.-based Gastroenterology of the Rockies. Mr. Richardson spoke with Becker's ASC Review about the influx of private equity in the ASC industry and how he thinks President Joe Biden's $1.9 trillion COVID-19 relief…

ASC owners and administrators have a new outlook on growth and expansion one year after the pandemic began.

ASCs can partner with private equity-backed platforms as a way to capitalize on future value and mitigate risks, but some ASC leaders warn that partnering with private equity firms requires consideration of costs outside the financial.

The ASC industry has seen an influx of private equity interest, consolidating the industry. Ophthalmologist Richard Lee, MD, who works at Oakland, Calif.-based Eye MD Laser & Surgery Center, spoke with Becker's ASC Review on why his ASC hasn't sold…

During COVID-19 surges last year, ASCs and hospitals worked together in new ways to care for patients across the U.S.

Peter Pronovost, MD, PhD, was named ValueHealth's chair of the advisory board on healthcare transformation.

Last year the pandemic forced many ASCs to close or limit surgical volume, but enterprising administrators took the time as an opportunity to evaluate their growth strategy, improve culture, acquire new technology and become more efficient.

Here's a roundup of ASCs hiring directors, drawn from LinkedIn's Job Search and Indeed: